Learn about MSK’s active surveillance program for papillary thyroid cancer, which allows many people to avoid unnecessary surgery and the risks that come with it.
Pharmac has decided to fund lenvatinib from 1 December 2024 for people with some types of thyroid, liver, and kidney cancer. Lenvatinib (branded as Lenvima) stops the number of cancer cells from ...
Medication and lifestyle changes can effectively manage the disease. To normalise hormone levels, the primary treatment is synthetic thyroid hormone replacement, usually in the form of medicine. This ...
Thyroid disease is emerging as a significant public health challenge in the Asia-Pacific (APAC) region, with a recent Economist Impact report highlighting that an estimated 11% of adults are affected ...